UNSPSC 51101673: Nifurtimox

This classification denotes an antiprotozoal agent with the molecular formula C10H13N3O5S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier M84I3K7C2O, chemically known as 4-thiomorpholinamine, 3-methyl-n-((5-nitro-2-furanyl)methylene)-, 1,1-dioxide but more generally known as nifurtimox, which bears U.S. National Institutes of Health Compound Identifier 6842999. The European Medicines Agency schedules Nifurtimox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09280MIG.

UNSPSC 51101673 Nifurtimox is a Commodity code designating a specific antiparasitic pharmaceutical product; however, the recent state and local opportunities tagged under this code reflect little alignment with nifurtimox procurement itself. Instead, the tagged records show state and local governments buying a broader range of pharmaceutical products and public-health supplies — including antibiotics, opioid-reversal agents, and drug-deactivation systems — through piggyback contracts, cooperative purchasing agreements, and competitive sealed bidding. The Illinois Department of Public Health sourced Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets via the MMCAP Infuse cooperative purchasing vehicle, while Seminole County, Florida sought Naloxone and Safe Drug Deactivation Systems through an IFB process. These procurements suggest state and local agencies use pharmaceutical commodity codes to acquire both routine clinical supplies and emergency-response medications, often bundling multiple products under single awards with multi-year terms and renewal options.

Geographic activity centers on Illinois and Florida based on recent postings. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract to Chartwell Rx LLC through August 2026 covering a 12-month initial term plus renewal options for years 2 and 3, while Seminole County released an IFB on June 30, 2026 with a July 26, 2023 response deadline for annual supplies of 1,900 units of Naloxone and 800 deactivation systems with quarterly delivery. State and county health departments and special-purpose districts appear to be the primary issuing bodies. The mismatch between the code's nominal scope (nifurtimox, a drug for parasitic infection) and the actual recent solicitations (antibiotics, naloxone, and deactivation systems) suggests either tagging inconsistency in the source records or that the code serves as a catch-all within state procurement systems for pharmaceutical products beyond its specific designation.